Galapagos NV header image

Galapagos NV

GLPG

Equity

ISIN null / Valor 3542077

NASDAQ (2026-11-03)
USD 32.15+0.41%

Galapagos NV
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Galapagos NV is a biotechnology firm specializing in oncology and the development of CAR-T therapies and biologics. In 2022, the company expanded its capabilities by acquiring CellPoint and AboundBio, thereby establishing comprehensive end-to-end CAR-T development processes. These acquisitions have enabled Galapagos to implement a decentralized T-cell manufacturing platform and utilize advanced fully human antibody technologies, positioning the company to innovate and advance next-generation CAR-T treatments and biologic therapies within the medical field.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

3.78%1Y
-13.2%3Y
-42.9%5Y

Performance

27.8%1Y
30.2%3Y
32.1%5Y

Volatility

Market cap

2119 M

Market cap (USD)

Daily traded volume (Shares)

129,706

Daily traded volume (Shares)

1 day high/low

27.4 / 26.99

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Strides Pharma Science Ltd
Strides Pharma Science Ltd Strides Pharma Science Ltd Valor: 1071169
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.14%INR 1,039.25
Terveystalo Oyj
Terveystalo Oyj Terveystalo Oyj Valor: 37893402
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.50%EUR 6.08
Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA Valor: 332902
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.47%EUR 48.81
Carl Zeiss Meditec AG
Carl Zeiss Meditec AG Carl Zeiss Meditec AG Valor: 1055489
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.46%EUR 35.00
AMN Healthcare Services Inc
AMN Healthcare Services Inc AMN Healthcare Services Inc Valor: 1269241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.03%USD 45.30
FibroGen Inc
FibroGen Inc FibroGen Inc Valor: 25953994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.36%USD 4.31
Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc Syndax Pharmaceuticals Inc Valor: 24112479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
9.08%USD 14.29
Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.37%USD 4.30
ALX Oncology Holdings Inc
ALX Oncology Holdings Inc ALX Oncology Holdings Inc Valor: 55754366
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.84%USD 1.29
Hims & Hers Health Inc
Hims & Hers Health Inc Hims & Hers Health Inc Valor: 59397181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.82%USD 25.70